Success Metrics

Clinical Success Rate
57.1%

Based on 4 completed trials

Completion Rate
57%(4/7)
Active Trials
9(53%)
Results Posted
0%(0 trials)
Terminated
3(18%)

Phase Distribution

Ph not_applicable
5
29%
Ph phase_1
2
12%
Ph phase_2
1
6%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
1(12.5%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

9

trials recruiting

Total Trials

17

all time

Status Distribution
Active(10)
Completed(4)
Terminated(3)

Detailed Status

Recruiting7
Completed4
Terminated3
Active, not recruiting2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
9
Success Rate
57.1%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (25.0%)
Phase 21 (12.5%)
N/A5 (62.5%)

Trials by Status

enrolling_by_invitation16%
recruiting741%
terminated318%
active_not_recruiting212%
completed424%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT06349642

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Recruiting
NCT04305366

MicroRNA Markers in Head and Neck Cancers

Active Not Recruiting
NCT06331676Not Applicable

Developing a Complex ex Vivo Endometrial Tissue Model to Improve Endometriosis Care

Recruiting
NCT06574620Not Applicable

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Recruiting
NCT06635980Phase 2

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Recruiting
NCT04323202Phase 1

Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N

Completed
NCT06482957

Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

Recruiting
NCT06976502

Health eHeart BioBank

Enrolling By Invitation
NCT02495337

Tissue Collection Protocol for Gastroesophageal Cancers

Recruiting
NCT05324553

Patient Derived Preclinical Models

Recruiting
NCT04239040Phase 1

GVAX Plus Checkpoint Blockade in Neuroblastoma

Terminated
NCT03735745Not Applicable

Transdisciplinary Oral/Oropharyngeal Cancer Research & Care in Head and Neck Cancer (TORCH)

Completed
NCT04223102Not Applicable

Microbiome and Rectal Cancer

Active Not Recruiting
NCT01510405

Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung Cancer

Completed
NCT02973750

Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer

Completed
NCT03862066

Memory Phenotype and PD-1 Inhibition Response in Oral Cancer

Terminated
NCT02441140Not Applicable

Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis

Terminated

All 17 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
17